Michael Thomas, DPM
Foot & Ankle Surgery · Red Bank, NJNPI 1073019402
Payments from drug & device makers
Across 57 payments — averaging $222.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Supreme Orthopedic Systems, LLC$2K
- Stryker$2K
- Orthofix Medical, Inc.$2K
- Summit Surgical Corp.$1K
- Paragon 28, Inc.$1K
- plus $1K from 10 others
What the payments were for
- Consulting fees$3993%
- Grants$1,36011%
- Travel & lodging$3,01924%
- Food & beverage$1,88415%
- Education$6,00047%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 10 | $2,944 |
| Supreme Orthopedic Systems, LLC | 5 | $2,492 |
| Stryker | 4 | $2,040 |
| Orthofix Medical, Inc. | 17 | $1,860 |
| Summit Surgical Corp. | 1 | $1,200 |
| Paragon 28, Inc. | 5 | $1,021 |
| Bone Support Inc. | 2 | $489 |
| Seapearl East, Inc | 3 | $198 |
| Sanara Medtech Inc. | 2 | $137 |
| Imbed Biosciences Inc. | 1 | $73 |
| Organogenesis Inc. | 1 | $53 |
| Treace Medical Concepts, Inc. | 2 | $52 |
| Johnson & Johnson | 1 | $45 |
| Electromed, Inc. | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TrueLok$1,324
- Portfolio$458
- CERAMENTBONE VOID FILLER$399
- APEX 3D$369
- MONKEY RINGS$140
- Physio-Stim$138
- CITREFIX$131
- AUGMENT INJECTABLE$131
- ALLOWRAP$131
- 7 X 23MM CITRELOCK IMPLANT$131
- CellerateRx$127
How this compares
$12,662 in reported general payments places this provider in the 85th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 116 | $2,909 |
| Ciclopirox | 48 | $1,181 |
| Mupirocin | 35 | $277 |
| Ammonium Lactate | 17 | $230 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $204 |
| Clindamycin Hcl | 19 | $170 |
| Meloxicam | 32 | $78 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Red Bank
- Wayne BerberianNewark$2M
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$847K
- Shane HollawellManasquan$753K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Sheldon LinNewark$253K
- Mark SolomonCedar Knolls$232K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.